the latest market report published by credence n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Heparin Market Size, Market Share, Trends & Growth Analysis, Industry Forecast To 2025 PowerPoint Presentation
Download Presentation
Heparin Market Size, Market Share, Trends & Growth Analysis, Industry Forecast To 2025

Loading in 2 Seconds...

play fullscreen
1 / 3

Heparin Market Size, Market Share, Trends & Growth Analysis, Industry Forecast To 2025 - PowerPoint PPT Presentation


  • 7 Views
  • Uploaded on

The latest market report published by Credence Research, Inc. “Heparin Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global heparin market was valued at US$ 7,714.0 Mn in 2016, and is expected to reach US$ 14,853.1 Mn by 2025 expanding at a CAGR of 7.21 % from 2017 to 2025. \nBrowse the full report Heparin Market - Growth, Future Prospects, Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/heparin-market\n

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Heparin Market Size, Market Share, Trends & Growth Analysis, Industry Forecast To 2025' - ConsuellaHunter


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
the latest market report published by credence

The latest market report published by Credence Research, Inc. “Heparin Market -

Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global heparin market

was valued at US$ 7,714.0 Mn in 2016, and is expected to reach US$ 14,853.1 Mn by 2025

expanding at a CAGR of 7.21 % from 2017 to 2025.

Browse the full report Heparin Market - Growth, Future Prospects, Competitive

Analysis,

2017

at http://www.credenceresearch.com/report/heparin-market

Market Insights

The heparin crisis which took place in 2008 due to contaminated batches of

unfragmented heparin imported from China resulted in fatal adverse events such as rapid

fall in blood pressure and death. This event led to the entry of more safe and effective low

and ultra-low molecular weight heparin. Still pharmacovigilence agencies have reported

several heparin related serious adverse events which demands for safer heparin products

for medicinal use. Researchers at University of North Carolina have developed a low

molecular weight heparin through chemoenzymatic process by using C5-epimerase and

recombinant O-sulfotransferase enzymes. The newly synthesized heparin will be reversed

by protamine sulphate and will be cleared by liver and not by the kidneys, and thus will

overcome the earlier heparin related adverse events.

Rising prevalence of venous thromboembolism and good bioavailability due to longer

half-life low molecular weight heparin leads the products segment. Ultra-low molecular

weight heparin will lead the market during the forecast period as it has projected better

results in DVT/PE induced in patients undergoing cancer chemotherapy.

Subcutaneous is the most desirable route of administration owing to excellent drug

pharmacokinetic profile for heparin and is relatively cheaper. Intravenous route is used

for its fast onset of action due to high plasma protein binding and is used to perform open

heart surgery, blood transfusion, and kidney dialysis.

North America is the clear leader in global heparin market as a result of rising prevalence

of venous thromboembolism. In United States about 33 % of the people suffering with

venous thromboembolism has a recurrence within ten years. Enhanced investment in the

research and development of heparin products to address the problems associated with

heparin overdose has a positive effect on market growth of North America. Increasing

number of venous thromboembolism encountered in patients undergoing cancer

chemotherapy and supportive regulatory environment for heparin products will be

responsible for the remarkable growth of Asia Pacific in global heparin market.

Market players engaged in the manufacture and sale of heparin products are Aspen

Holdings, Teva Pharmaceutical Industries Ltd., Baxter International, Inc., Syntex S.A., B.

Braun Melsungen AG, Sanofi AG, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., LEO Pharma

A/S., and Fresenius SE & Co. KGaA among others.

Key Market Movements

2025

report

rising prevalence of venous thromboembolism

Rising prevalence of venous thromboembolism and pulmonary embolism

Increasing research activities conducted on ultra-low molecular weight heparin

and synthetic heparin reporting promising therapeutic applications

Patent expiry of low molecular weight heparin will boost the generic market in the

near future

Related

https://www.credenceresearch.com/industry/pharmaceuticals-market

Table of Content

 Chapter 1. Preface

1.1. Report Scope and Description

1.2. Research Methodology

1.2.1. Phase I-Secondary Research

1.2.2. Phase II-Primary Research

1.2.3. Phase III-Expert Panel Review

1.2.4. Assumptions

1.2.5. Approach Adopted

Chapter 2. Executive Summary

2.1. Global Heparin Market Portraiture

2.1.1. Global Heparin Market, by Product, 2016 (Value %)

2.1.2. Global Heparin Market, by Route of Administration, 2016 (Value %)

2.1.3. Global Heparin Market, by Geography, 2016 (Value %)

Chapter 3. Heparin Market: Dynamics and Future Outlook

3.1. Market Overview

3.2. Drivers

3.3. Challenges

3.4. Opportunities

3.5. Attractive Investment Proposition, by Geography

3.6. Top 3 Countries: Global Heparin Market, 2015-2025 (US$ Mn)

3.7. Competitive Landscape : Global Heparin Market, by Key Players, 2015-2025

(US$ Mn)

Chapter 4. Global Heparin Market, by Product, 2015 – 2025 (US$ Mn)

4.1. Overview

4.2. Attractive Investment Proposition: Global Heparin Market, by Product, 2016

4.3. Unfractionated Heparin

4.4. Low Molecular Weight Heparin

4.5. Ultra-Low Molecular Weight Heparin

Chapter 5. Global Heparin Market, by Route of Administration, 2015 –

2025 (US$ Mn)

5.1. Overview

Reports-

5 1 1 attractive investment proposition global

5.1.1. Attractive Investment Proposition: Global Heparin Market, by Route of

Administration, 2016

5.2. Subcutaneous

About Us:

Credence Research is a worldwide market research and counseling firm that serves

driving organizations, governments, non-legislative associations, and not-for-benefits.

We offer our customers some assistance with making enduring enhancements to their

execution and understand their most imperative objectives. Over almost a century, we’ve

manufactured a firm extraordinarily prepared to this task.

Latest Report

https://www.credenceresearch.com/report/gasket-and-seals-market

https://www.credenceresearch.com/report/metabolomics-market

https://www.credenceresearch.com/report/malic-acid-market

Media Contact

Name: Chris Smith

Designation: Global Sales Manager

Ph: 1-800-361-8290

Email: sales@credenceresearch.com

Web: http://www.credenceresearch.com/